Search research articles
Contact Us
Filters
Showing results (231-240 of 255) with videos related to
Page
of 26
Sort By:
Journal of Affective Disorders
|
July 19, 2023
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study
Sabrina M Darrow, Diego A Pizzagalli, Moria Smoski, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
The Journal of Clinical Psychiatry
|
June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
Richard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Schizophrenia Research
|
March 25, 2023
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders
Lusi Zhang, Paulo Lizano, Yanxun Xu, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 15, 2025
Beyond symptom improvement: transdiagnostic and disorder-specific ways to assess functional and quality of life outcomes across mental disorders in adults
Christoph U Correll, Samuele Cortese, Marco Solmi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 10, 2021
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders
Lusi Zhang, Scot Kristian Hill, Bin Guo, et al.
Archives of General Psychiatry
|
June 10, 2010
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis
Larry J Seidman, Anthony J Giuliano, Eric C Meyer, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Nature Medicine
|
April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Andrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 255) with videos related to
Sort By:
Page
of 26
Journal of Affective Disorders
|
July 19, 2023
Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study
Sabrina M Darrow, Diego A Pizzagalli, Moria Smoski, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Christine E Marx, Richard S E Keefe, Robert W Buchanan, et al.
The Journal of Clinical Psychiatry
|
June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
Richard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Schizophrenia Research
|
March 25, 2023
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders
Lusi Zhang, Paulo Lizano, Yanxun Xu, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 15, 2025
Beyond symptom improvement: transdiagnostic and disorder-specific ways to assess functional and quality of life outcomes across mental disorders in adults
Christoph U Correll, Samuele Cortese, Marco Solmi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 10, 2021
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders
Lusi Zhang, Scot Kristian Hill, Bin Guo, et al.
Archives of General Psychiatry
|
June 10, 2010
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis
Larry J Seidman, Anthony J Giuliano, Eric C Meyer, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Nature Medicine
|
April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Andrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Page
of 26